Effect of the angiotensin-converting enzyme inhibitor perindopril on haemostasis in essential hypertension

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 7, 2000, Pages 641-644

  Remková, Anna ^a   Kratochvil'ova H ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Essential hypertension; Haemostasis; Perindopril therapy

Indexed keywords

ANTITHROMBIN III; D DIMER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIN MONOMER; FIBRINOGEN; PERINDOPRIL; PLACEBO; PLASMINOGEN; PROTEIN C; PROTEIN S;

ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; STAGING; VASCULAR DISEASE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD COAGULATION TESTS; BLOOD PRESSURE; CONFIDENCE INTERVALS; FEMALE; FIBRINOLYTIC AGENTS; HEMOSTASIS; HEMOSTATICS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERINDOPRIL; TIME FACTORS;

EID: 0033767333     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200010000-00008     Document Type: Article

References (22)

1. Elevated fibrinogen and plasminogen activator inhibitor (PAI 1) in hypertension are related to metabolic risk factors for cardiovascular disease
2. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina
3. Effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril on endothelial and platelet functions in essential hypertension
4. Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial and platelet function in essential hypertension
5. Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension
6. The effect of prazosin therapy on platelet activation in essential hypertension
7. Hypertension and propranolol therapy: Effect on blood pressure, plasma catecholamines and platelet aggregation
8. Platelet aggregation in hypertension and the effects of anti-hypertensive treatment
9. Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism
10. Platelet function during anti-hypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor
11. ACE inhibitor effects on platelet function in stages I-II hypertension
12. Effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: A randomly allocated double-blind study
13. General pharmacology of ramipril
14. Treatment of hypertension with captopril: Preservation of regional blood flow and reduced platelet aggregation
15. A dose-response study of perindopril in hypertension: Effects on blood presssure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group
16. Effect of long-term celiprolol therapy on haemostasis in essential hypertension
17. Effect of isradipine on factors affecting blood viscosity
18. Reduced protein C levels in patients with essential hypertension
19. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients
20. Platelet and leukocyte activation after myocardial infarction. Influence of enalapril